UnitedHealth/$UNH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About UnitedHealth
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Ticker
$UNH
Sector
Primary listing
NYSE
Employees
400,000
Headquarters
Website
UnitedHealth Metrics
BasicAdvanced
$323B
15.43
$23.12
0.45
$8.62
2.48%
Price and volume
Market cap
$323B
Beta
0.45
52-week high
$613.92
52-week low
$234.60
Average daily volume
11M
Dividend rate
$8.62
Financial strength
Current ratio
0.846
Quick ratio
0.765
Long term debt to equity
70.14
Total debt to equity
75.577
Dividend payout ratio (TTM)
36.54%
Interest coverage (TTM)
7.50%
Profitability
EBITDA (TTM)
33,577
Gross margin (TTM)
20.84%
Net profit margin (TTM)
5.04%
Operating margin (TTM)
7.27%
Effective tax rate (TTM)
16.94%
Revenue per employee (TTM)
$1,060,000
Management effectiveness
Return on assets (TTM)
6.46%
Return on equity (TTM)
21.65%
Valuation
Price to earnings (TTM)
15.427
Price to revenue (TTM)
0.772
Price to book
3.41
Price to tangible book (TTM)
3.23
Price to free cash flow (TTM)
12.89
Free cash flow yield (TTM)
7.76%
Free cash flow per share (TTM)
27.664
Dividend yield (TTM)
2.42%
Forward dividend yield
2.48%
Growth
Revenue change (TTM)
9.70%
Earnings per share change (TTM)
52.72%
3-year revenue growth (CAGR)
11.31%
10-year revenue growth (CAGR)
11.83%
3-year earnings per share growth (CAGR)
6.50%
10-year earnings per share growth (CAGR)
13.91%
3-year dividend per share growth (CAGR)
12.36%
10-year dividend per share growth (CAGR)
18.01%
What the Analysts think about UnitedHealth
Analyst ratings (Buy, Hold, Sell) for UnitedHealth stock.
Bulls say / Bears say
UnitedHealth appointed Patrick Conway as CEO of its Optum services arm, leveraging his expertise in value-based care to drive growth and improve performance in its fastest-growing division. (Reuters)
UnitedHealth forecasts that 78% of its Medicare Advantage members will be enrolled in 4-star or higher plans for 2026, positioning the company to capture substantial CMS bonus payments and enhanced reimbursements. (Reuters)
Optum Rx’s initiative to cut up to 25% of annual prescription reauthorization requirements eases administrative burdens for members and may lower costs, strengthening competitive differentiation in pharmacy benefit management. (Reuters)
UnitedHealth’s full-year 2025 EPS forecast was slashed to at least $16, well below analysts’ $20.91 estimate, as accelerating medical cost trends were significantly underestimated, triggering a nearly 5% drop in shares. (Reuters)
To resolve antitrust concerns over its $3.3 billion Amedisys acquisition, UnitedHealth must divest 164 hospice and home health locations, risking integration synergies and potential revenue dilution. (Reuters)
A DOJ criminal probe into Optum Health’s billing practices for in-home visits heightens regulatory risk and may result in fines or operational restrictions for the company’s healthcare services arm. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 27 Sept 2025.
UnitedHealth Financial Performance
Revenues and expenses
UnitedHealth Earnings Performance
Company profitability
UnitedHealth News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for UnitedHealth stock?
UnitedHealth (UNH) has a market cap of $323B as of October 18, 2025.
What is the P/E ratio for UnitedHealth stock?
The price to earnings (P/E) ratio for UnitedHealth (UNH) stock is 15.43 as of October 18, 2025.
Does UnitedHealth stock pay dividends?
Yes, the UnitedHealth (UNH) stock pays dividends to shareholders. As of October 18, 2025, the dividend rate is $8.62 and the yield is 2.48%. UnitedHealth has a payout ratio of 36.54% on a trailing twelve-month basis.
When is the next UnitedHealth dividend payment date?
The next UnitedHealth (UNH) dividend payment date is unconfirmed.
What is the beta indicator for UnitedHealth?
UnitedHealth (UNH) has a beta rating of 0.45. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.